Nationwide Recall of Ice Cream Due to Possible Plastic Contamination
A nationwide recall has been issued for thousands of tubs of ice cream and frozen yogurt due to possible plastic contamination. Consumers should check their products and return or discard affected items to ensure safety.
In a significant recall effort, nearly 18,000 tubs of ice cream and frozen yogurt have been voluntarily pulled from the market over concerns of plastic particles being present in the products. The manufacturer, Wells Enterprises, based in Iowa, announced the recall last month. The company’s brands include well-known names such as Blue Bunny and Halo Top.
The recall affects 22 different flavors packaged in three-gallon containers, with 'Best If Used By' dates ranging from March to October 2026. These products were distributed across various channels, including food service suppliers, restaurants, and retail outlets. Notable distributors include Gordon Food Service, US Foods, and Sysco Corp, along with restaurant chains like Johnny Rockets and smoothie chains like Planet Smoothie.
The U.S. Food and Drug Administration (FDA) has listed these products on its official website but has not issued a formal press release. Consumers who own any of the affected products are advised not to open or consume them. Instead, they should return the items to the place of purchase for a refund or dispose of them to prevent accidental ingestion.
This recall raises awareness about food safety issues related to contamination and highlights the importance of strict quality control processes in food manufacturing. The potential presence of plastic pieces poses health risks, and consumers are urged to heed the recall notices to ensure safety.
For more details, the FDA provides additional information about the recall on its official site.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
SGLT2 Inhibitors Show Safety and Efficacy for Kidney Preservation After Heart Attack
New research shows that SGLT2 inhibitors like empagliflozin are safe and effective for preserving kidney function and reducing heart failure risk in patients after a heart attack, expanding their potential use in post-cardiac event treatment.
Surviving Serious Neonatal Health Issues May Increase Risk into Adolescence
Children who survive serious health problems at birth face a higher risk of mortality during childhood and adolescence. A new study highlights the importance of long-term support and follow-up for these vulnerable children.
Updated Pediatric Venous Thromboembolism Treatment Guidelines Now Available
The American Society of Hematology and ISTH have published updated guidelines for managing pediatric venous thromboembolism, emphasizing new anticoagulant options and improved care strategies.
Innovative Gene Therapy Protects Hearing and Balance in Preclinical Studies
A groundbreaking gene therapy from Tel Aviv University effectively preserves hearing and balance in preclinical models, promising new treatments for genetic ear disorders.